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The transcription factor Bcl6 (B cell lymphoma 6) 
is rapidly induced upon peripheral activation of 
CD4+ T cells and plays a central role in the acqui-
sition of the T follicular helper (Tfh) cell program 
(Crotty, 2011; Nutt and Tarlinton, 2011; Vinuesa 
and Cyster, 2011; Liu et al., 2013) and in antago-
nizing other T effector programs (Nurieva et al., 
2009; Choi et al., 2011; Nakayamada et al., 2011; 
Pepper et al., 2011). Recent studies have identi-
fied Batf (basic leucine zipper transcription factor, 
ATF-like), an AP-1 factor, as a critical determi-
nant of Bcl6 induction and a global regulator of 
the Tfh program (Betz et al., 2010; Ise et al., 2011). 
Thus, Batf binds and activates the promoter of 
Bcl-6, as well as several other key Tfh genes, in-
cluding cMaf and Il21, and Tfh development is 
severely impaired in its absence. Batf is also a 
global regulator of the RORt-driven Th17 
cell differentiation (Schraml et al., 2009), which 
Bcl6 inhibits (Nurieva et al., 2009; Yu et al., 2009; 
Lu et al., 2011). Recent studies demonstrated that 
Batf binds cooperatively with Irf4 to composite 
genomic sequences found in the regulatory re-
gions of multiple genes involved in Tfh, Th17, and 
Th2 programs, highlighting the central impor-
tance of these factors in the emergence of effector 
programs (Ciofani et al., 2012; Glasmacher et al., 
2012; Li et al., 2012; Tussiwand et al., 2012).
Intriguingly, both RORt and Bcl6 are 
transiently expressed during T cell development 
at the CD4+CD8+ double-positive (DP) stage 
(Sun et al., 2000; Hyjek et al., 2001). Although 
RORt is essential to prolong the lifespan of 
DP thymocytes as they undergo successive re-
arrangements of their TCR  locus (Guo et al., 
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Induction of Bcl6 (B cell lymphoma 6) is essential for T follicular helper (Tfh) cell differentia-
tion of antigen-stimulated CD4+ T cells. Intriguingly, we found that Bcl6 was also highly and 
transiently expressed during the CD4+CD8+ (double positive [DP]) stage of T cell development, 
in association with the E3 ligase cullin 3 (Cul3), a novel binding partner of Bcl6 which ubiq-
uitinates histone proteins. DP stage–specific deletion of the E3 ligase Cul3, or of Bcl6, in-
duced the derepression of the Bcl6 target genes Batf (basic leucine zipper transcription 
factor, ATF-like) and Bcl6, in part through epigenetic modifications of CD4+ single-positive 
thymocytes. Although they maintained an apparently normal phenotype after emigration, 
they expressed increased amounts of Batf and Bcl6 at basal state and produced explosive and 
prolonged Tfh responses upon subsequent antigen encounter. Ablation of Cul3 in mature 
CD4+ splenocytes also resulted in dramatically exaggerated Tfh responses. Thus, although 
previous studies have emphasized the essential role of Bcl6 in inducing Tfh responses, our 
findings reveal that Bcl6–Cul3 complexes also provide essential negative feedback regulation 
during both thymocyte development and T cell activation to restrain excessive Tfh responses.
© 2014 Mathew et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Figure 1. Excessive Tfh formation in Cul3fl/fl Cd4-cre mice. (a) FACS analysis of thymic CD4+ SP, RTEs, and splenic CD4+ in 10–15-wk-old Cul3cKO and 
littermate (LM) controls. Numbers indicate percentage (mean ± SEM) of CXCR5+PD1+ Tfh cells among two to eight mice/group from two to four independent 
experiments. (b) Tfh cell numbers in 16-wk-old Cul3cKO and littermate control splenic, mesenteric, cervical, and pancreatic lymph nodes, inguinal/axillary lymph 
nodes, and Peyer’s patches. Data are a compilation of two to six independent experiments with a total of 3–11 mice. (c) Mixed bone marrow chimeras reconstituted 
with various KO/WT bone marrow cell ratios analyzed for Tfh frequency 10 wk after reconstitution. Data are representative of two to three mixed chimeras per group 
from two independent experiments. (d) FACS analysis of splenic CD4+ Tfh, T reg, and Tfr cells from 9-wk-old Cul3cKO and littermate control mice. The leftmost column 
shows the gating strategy for CD4+Foxp3 and CD4+Foxp3+ cells. Data represent two independent experiments with a total of three mice each examined. 
Values represent the percentage of cells (mean ± SEM). (e) qRT-PCR analysis of cMaf and Il21 in splenic CD4+ T cells (sorted as CD4+CD25CD1d-PBS57-tetramer) 
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clearly cell intrinsic, but a modest Tfh conversion of WT cells 
could also be observed at high KO/WT ratio (Fig. 1 c), sug-
gesting some bystander effect, perhaps caused by increased ex-
pression of the Tfh-promoting factors cMaf and Il21 (Fig. 1 e).
The Tfh and GC B cell expansions developed progres-
sively over the normal lifespan of Cul3cKO mice, with only 
slightly increased antinuclear antibodies detected in old age, 
2002), there is currently no thymic function assigned to Bcl6. 
Bcl6 is a BTB-ZF transcription factor that can recruit core-
pressor and coactivator complexes to establish epigenetic 
marks at target genes (Basso and Dalla-Favera, 2012). Thus, 
thymic expression of Bcl6, even transient, might induce last-
ing changes in T cells emerging from development.
We recently identified cullin 3 (Cul3), an E3 ubiquitin 
ligase known to use BTB proteins as adaptors for substrate 
recognition, as a component of the transcriptional complex 
associated with the NKT lineage–specific BTB-ZF transcription 
factor PLZF (Mathew et al., 2012). Cul3 induced the ubiqui-
tination of histones and of the genome organizers SATB1 and 
lamin B1, suggesting regulation at the chromatin level. Condi-
tional ablation of Cul3 in Cd4-cre+/Cul3fl/fl (Cul3cKO) mice 
led to a block in NKT thymic development similar to the 
PLZF-null mutation. Intriguingly, the mutant mice also exhib-
ited a spontaneous increase in the frequency of Tfh and ger-
minal center (GC) B cells in peripheral tissues (Mathew et al., 
2012). Here, we identified a negative feedback loop whereby 
Bcl6–Cul3 complexes repressed Batf and Bcl6 during thymic 
development. This thymic regulation was associated with last-
ing repressive epigenetic marks that limited the Tfh potential 
of mature CD4+ T cells upon subsequent encounter with anti-
gen in peripheral lymphoid tissues. A similar negative autoreg-
ulatory feedback operated in peripheral CD4+ T cells because 
deletion of Cul3 in mature T cells also unleashed exaggerated 
Tfh responses to antigen. Thus, although previous studies have 
emphasized the essential role of Bcl6 in inducing Tfh responses 
(Crotty, 2011; Nutt and Tarlinton, 2011; Vinuesa and Cyster, 
2011; Liu et al., 2013), our experiments have uncovered an es-
sential negative autoregulation of the Tfh program exerted by 
Bcl6–Cul3 complexes and revealed its unexpected importance 
as early as in thymic development.
RESULTS
Spontaneous Tfh expansion in Cul3-deficient mice
Cul3cKO mice show spontaneous enlargement of secondary 
lymphoid tissues because of the selective accumulation of Tfh 
cells and the resulting expansion of GC B cells, whereas other 
T helper responses are unaffected (Mathew et al., 2012). We 
found that the Tfh phenotype was not observed in thymic 
CD4+ single-positive (SP) cells or in recent thymic emigrants 
(RTEs) but developed progressively in the spleen and in mes-
enteric, cervical, and pancreatic lymph nodes, whereas axillary/
inguinal lymph nodes and Peyer’s patches were much less af-
fected (Fig. 1, a and b). Interestingly, although the Tfh expan-
sion was mostly made of conventional CD4+ T cells, it also 
included Foxp3+ T follicular regulatory (Tfr) cells (Fig. 1 d). 
In lethally irradiated mice reconstituted with CD45 congenic 
mixtures of WT and KO bone marrows, the T cell defect was 
from unimmunized 6–8-wk-old mice shown as the ratio of Cul3cKO/littermate control (n = 5 for each group from three independent experiments; mean ± SEM). 
(f) Hep-2 antinuclear antibodies quantified as mean nuclear fluorescence intensity at 1:40 dilution of sera from 30–50-wk-old Cul3cKO (seven females and one 
male) and WT littermates (four females), along with a positive control serum from MRLlpr/lpr and a no-serum negative control. (b and f) Horizontal bars indicate 
mean. (g) Survival curves of cohorts of Cul3cKO mice (n = 21) and WT littermates (n = 19; mean ± SEM). *, P < 0.05; ***, P < 0.001.
 
Figure 2. TCR- and SAP-dependent Tfh formation. (a) FACS analysis 
of splenic CD4+ T cells from 10-wk-old OTII Tg with intact or deleted Cul3 
as indicated. CD4+ cells gated as TCR Tg+ or TCR Tg were stained for 
ICOS and PD1 to measure the frequency of Tfh cells. Numbers represent 
mean ± SEM of five mice per group from two independent experiments.  
(b) FACS analysis of gated CD4+ splenocytes from 10–15-wk-old litter-
mate (LM) controls, Sh2d1a (SAP)/, Cul3cKO, and Sh2d1a/ Cul3cKO 
mice, stained for PD1 and CXCR5 (top) or PD1 and ICOS (bottom). (c) FACS 
analysis of the same spleens as in b, gated on B220+IgD cells to identify 
GC B cells. Numbers represent the percentage (mean ± SEM) of five mice/
group from three independent experiments in corresponding gates. For 
CD4+ T cells, GC-Tfh cells are identified as PD1hiICOShiCXCR5hi and pre-Tfh 
cells as intermediate for the same markers as shown.
o
n
 D
ecem
ber 22, 2016
D
ow
nloaded from
 
Published May 26, 2014
1140 Cullin 3 limits the Tfh program | Mathew et al.
Figure 3. Exaggerated Tfh responses to OVA antigen. (a and b) 0.5 × 106 CD4+ enriched SP thymocytes from OTII Tg or OTII Tg Cul3cKO donors 
were injected i.v. into CD45 congenic recipients 24 h before i.p. immunization with OVA + alum (a) or OVA-NP16 + alum (b). (a) Unimmunized controls 
are shown at day 3 after transfer in the first column, and immunized mice are shown at days 3 and 7 in the second and third columns. Summary data 
were compiled from two separate experiments, each with four to five mice per group, and statistical analyses are shown on the right. FACS analysis 
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PD1 (programmed cell death 1), and ICOS were not detectably 
increased in the absence of immunization. Thus, Cul3 abla-
tion at the DP stage resulted in delayed but stable increases of 
basal Batf and Bcl6 proteins, without overt Tfh transforma-
tion, suggesting that some degree of Tfh dysregulation was al-
ready present before antigen exposure.
After immunization, PD1hiCXCR5hi Cul3cKO Tfh cells 
appeared earlier, expanded faster, and were maintained longer 
than WT Tfh cells (Fig. 3 a, top two rows). As soon as day 3 after 
immunization, 62 ± 2% of Cul3cKO cells expressed very high 
levels of PD1 and CXCR5 compared with only 33 ± 3% of 
WT. A similar increase was noted for ICOS, GL7, BTLA, and 
OX40 (not depicted). At day 7, when WT cells were already 
losing their Tfh phenotype, Cul3cKO cells kept expressing 
even higher levels of the Tfh markers, reaching 72 ± 5% com-
pared with 13 ± 6% for controls. These differences were con-
firmed in multiple independent experiments and were highly 
significant (P < 0.001). This exaggerated Tfh response was as-
sociated with a rise of Batf and Bcl6 detected by intracellular 
flow cytometry, which occurred earlier and reached higher and 
more sustained levels than WT cells (Fig. 3 a, bottom four rows). 
Importantly, after immunization with OVA-NP16 mixed with 
alum, the Cul3cKO OTII cells drove correspondingly higher 
titers of anti-NP antibodies detected by ELISA with BSA-
NP41, as well as high-affinity antibodies detected with BSA-
NP4, indicating normal Tfh functions (Fig. 3 c).
The exaggerated Tfh response was associated with increased 
expression of Ki67, suggesting markedly increased prolifera-
tion of Cul3cKO Tfh cells (Fig. 4 a, second row). It did not 
appear to occur at the expenses of other T helper programs 
because Cul3cKO mice immunized with OVA mixed with 
alum or with OVA mixed with CFA exhibited the same bias 
toward Gata3+ Th2 cells or Tbet+ Th1 cells, respectively (Fig. 4, 
a and b). Altogether, these results indicated that although 
Cul3cKO CD4+ T cells exhibited baseline increases in Batf and 
Bcl6 after exiting the thymus, they acquired their exaggerated 
Tfh cell differentiation after immunization in the periphery.
Altered Tfh gene expression in Cul3-deficient thymocytes
The stable baseline increase of Batf and Bcl6 proteins observed 
shortly after thymic maturation of Cul3cKO CD4+ T cells sug-
gested that fresh thymocytes might already express detectable 
changes at the transcriptional level. Using quantitative real-time 
PCR (qRT-PCR), we measured the Batf transcript levels in 
large and small DP thymocytes, as well as in CD4+ SP thymo-
cytes. Fig. 5 a shows that although Batf transcripts were not 
but without overt disease or notable anomalies in blood cell 
counts or in function and histology of lung, liver, and kidney 
(Fig. 1, f and g; and not depicted). Altogether, the general 
picture was suggestive of exaggerated Tfh responses to envi-
ronmental antigens at mucosal surfaces, without overt im-
munopathological consequences in the B6 background.
Tfh expansion is antigen driven and  
SLAM-associated protein (SAP) dependent
To test whether the Tfh expansion was dependent on antigen 
stimulation, we crossed the Cul3cKO mice to OTII TCR 
transgenic (Tg) mice. As shown in Fig. 2 a, a Tfh expansion still 
occurred in TCR Tg mice, but it was strictly restricted to the 
cells that expressed endogenous TCRs (V2loV5lo), whereas 
the cells expressing high levels of Tg V2 and V5 were not 
involved. Thus, Tfh expansion depended on TCR specificity.
Tfh cell differentiation occurs in two steps, including a 
pre-Tfh stage, characterized by intermediate levels of Tfh 
markers, and a GC-Tfh stage, which depends on SAP-mediated 
interactions with B cells. Upon deletion of SAP in Cul3-
deficient T cells, the expansion of GC-Tfh and GC B cells 
was markedly decreased (Fig. 2, b and c). However, the pre-
Tfh population was still expanded. Thus, Cul3-deficient Tfh 
cells differentiated along the classical SAP-independent pre-
Tfh and SAP-dependent GC-Tfh stages, and their expansion 
was initiated before GC entry.
Dysregulation of Tfh-inducing transcription factors  
before antigen encounter and exaggerated Tfh  
responses after immunization
We transferred 0.5 × 106 WT or Cul3cKO CD4+ enriched SP 
OTII thymocytes i.v. into unirradiated CD45 congenic recipi-
ents to study their response after immunization with cognate 
antigen OVA in alum. First, we followed unimmunized recipi-
ents. Surprisingly, we noted that, although both CD4+ SP thy-
mocytes and 24-h RTEs in Cul3cKO mice failed to express 
CXCR5 (chemokine [C-X-C motif] receptor 5) and other 
surface Tfh markers (Fig. 1 a), the transferred cells expressed 
conspicuously higher amounts of basal Batf (67%) and Bcl6 
(41%) on average than their WT counterparts 3 d after transfer, 
as measured by intracellular flow cytometry (Fig. 3, a [left col-
umn] and b). These increased basal levels were maintained 
without further increase at day 7 after transfer (Fig. 3 b). How-
ever, these changes were not sufficient to induce the acquisition 
of the stereotypical Tfh phenotype because levels of CXCR5, 
shows staining of gated donor cells in the spleen for PD1 and CXCR5 (top two rows), Batf (middle two rows), Bcl6 (bottom two rows). Numbers above 
panels in the top two rows represent absolute numbers of donor cells recovered in the recipient spleens (mean ± SEM), with the percentage of 
PD1hiCXCR5hi cells indicated in the top right quadrant of each dot plot. In the bottom four rows, numbers represent mean fluorescence intensity (MFI), 
with shaded gray histograms representing background staining. (b) Comparative levels of Batf and Bcl6 proteins (expressed as OTII Cul3cKO/WT MFI 
ratio) in CD4+ SP thymocytes before (day 0) and after parking for 3 and 7 d (in vivo transfer) in individual unimmunized mice. Data are combined 
from two independent experiments with four to eight mice in each group. (c) Serum IgG1 antibodies against BSA-NP41 (left) and BSA-NP4 (right) at 
days 0 and 21 after immunization with OVA-NP16 + alum. Data are a compilation of two independent experiments, with a total of eight immunized 
mice in each group. Horizontal bars indicate mean. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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quantitatively altered at the early, large-DP stage in Cul3cKO 
mice, they were already significantly increased at the small-DP 
stage compared with littermate controls and further elevated 
at the SP stage. This kinetics was consistent with the genetic 
ablation of Cul3 at the early DP stage by the Cd4-Cre transgene. 
Thus, although increased Batf protein was detected soon after 
thymic emigration at the single cell level, transcriptional changes 
were already evident at the DP stage immediately after Cul3 
ablation. A similar picture was noted for Bcl6, which was ex-
pressed at a higher level in Cul3cKO than in WT CD4+ SP 
thymocytes (Fig. 5 b). Importantly, these alterations were cell 
intrinsic, as the analysis included several mixed (1:1) bone mar-
row chimeras in which Cul3cKO and WT CD4+ SP thymo-
cytes could be compared side by side.
We performed a comparative whole genome microarray 
analysis of CD4+ SP thymocytes in WT and Cu3-deficient 
littermates and examined a larger Tfh set of 14 genes, defined 
based on previously published work (Vinuesa et al., 2005; 
Nurieva et al., 2008; Yusuf et al., 2010), which included Slamf6, 
Il21, Cxcr5, Maf, Icos, Irf4, Batf, Bcl6, Pdcd1, Sh2d1a, Tiam1, 
Stat4, Tnfsf11, and Cd44. By examining gene resolution fold 
changes of Cul3cKO over WT with biological replicates plot-
ted as x and y axes, we found that Tfh genes were particularly 
up-regulated relative to other genome-wide changes in ex-
pression (Fig. 5 c). The Tfh-specific up-regulation was highly 
significant, as shown by comparing the Tfh gene set with ran-
domly generated sets of genes using Monte Carlo–generated 
simulations (P = 2 × 106). In contrast, a similar analysis of 
the Th1 and Th2 gene sets (detailed in the Materials and 
methods section) failed to show significant enrichment in 
Cul3cKO compared with WT CD4+ SP thymocytes, con-
firming the Tfh-specific nature of the thymic changes.
Figure 4. Exaggerated Tfh responses without alteration of Th1 or Th2 programs. (a and b) 0.5 × 106 CD4+ enriched SP thymocytes from OTII or 
OTII Cul3cKO donors were injected i.v. into CD45 congenic recipients 24 h before injection of OVA + CFA s.c., OVA + alum i.p., or PBS, as indicated. OTII 
cells were analyzed at day 7 after immunization in inguinal lymph nodes (CFA; a) or spleen (alum; b). (first row) Expression of CXCR5 and PD1. Numbers 
above the dot plots are the absolute numbers of OTII cells recovered from the lymph nodes or spleen. Numbers in top right quadrants are the percentage 
of CXCR5+PD1+ (mean ± SEM). (second row) Expression of Ki67 and CXCR5. (third row) Expression of Tbet and Bcl6. Numbers indicate the percentage 
(mean ± SEM) of TbethiBcl6hi cells (right box) or TbethiBcl6int cells (left box). Background staining is shown after preincubation with an excess of unconju-
gated antibodies (cold Tbet+Bcl6). (fourth row) Expression of Gata3 and CXCR5 with quadrant statistics (mean ± SEM). Background staining is shown for 
fluorochrome-conjugated isotype control. Data are representative of two independent experiments with total n = 6 mice.
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with APC and peptide, Cul3cKO CD4+ SP OTII thymocytes 
exhibited a massive increase of Batf, compared with WT 
cells, over a large range of peptide antigen concentrations, 
but, importantly, other proteins induced by TCR signaling 
TCR-independent up-regulation of Batf
Recent studies suggested a potential correlation between 
strength of TCR signaling and Tfh responses (Fazilleau 
et al., 2009; Tubo et al., 2013). When stimulated in vitro 
Figure 5. Altered Tfh gene expression in Cul3-deficient thymocytes. (a) qRT-PCR analysis of Batf in large DP, small DP, and CD4+ SP thymocytes 
shown as ratio of Cul3cKO/littermate (LM) control. (b) qRT-PCR analysis of Batf and Bcl6 in CD4+ SP thymocytes shown as ratio of Cul3cKO/littermate 
control. Bar graphs represent mean ± SEM from 5–10 pairs of KO and controls from five independent experiments. (c) Gene resolution fold changes of 
CD4+ SP thymocyte microarrays in Cul3cKO versus littermate controls, with biological replicates plotted as x- and y-axis coordinates. The Tfh gene set, 
indicated as large black scatter, is significantly up-regulated relative to other genome-wide changes in expression, as shown by comparative SSMD analy-
sis of Monte Carlo–generated sets (P = 2 × 106). In contrast, the Th1 and Th2 gene sets (not indicated in the figure) were not significantly altered (P = 0.3). 
(d) CD69-MACS–depleted OTII Tg thymocytes were stimulated with T cell–depleted CD45 congenic splenic APCs at different concentrations of OVA 
peptide for 20 h before FACS analysis of CD4+ SP cells for surface CD69 and intracellular Batf. Mean ± SEM of two independent experiments with three 
WT and three Cul3cKO is shown. (e) MHC II–deficient hosts were lethally irradiated and reconstituted with bone marrow cells from OTII Tg in a Cul3cKO or 
WT background as indicated. CD4/CD8 dot plots show absence of SP thymocytes at 5–6 wk after reconstitution, as expected. Bar graph shows Batf ex-
pression measured by qRT-PCR as a ratio of Cul3cKO/WT purified small DP thymocytes (mean ± SEM). Data are compiled from three WT and six KO from 
two independent experiments. (f) Same experiment as in panel e for MHC I/II double-deficient hosts reconstituted with Cul3cKO or WT bone marrow cells 
as indicated. Data are compiled from three WT and three KO from one experiment. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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such as CD69 were at similar levels, indicating the specific 
nature of Batf dysregulation and the absence of global alter-
ation of TCR signaling (Fig. 5 d). We also asked whether 
the Tfh bias might be dependent on TCR signaling events 
during thymic development. We transplanted bone marrow 
from OTII Tg mice with a WT or Cul3cKO background 
into lethally irradiated MHC II–deficient hosts. Although, 
as expected, the TCR Tg thymocytes did not progress be-
yond the DP stage in these chimeras because of lack of posi-
tive selection, Fig. 5 e shows that Cul3cKO DP thymocytes 
did up-regulate Batf transcripts (compared with WT DP) in 
the MHC II–deficient background as well, indicating that 
the up-regulation was independent of TCR engagement. 
A similar conclusion was derived from the analysis of un-
selected DP thymocytes obtained from MHC I/II double 
KO irradiated recipients reconstituted with WT or Cul3cKO 
bone marrow (Fig. 5 f). Thus, the basal up-regulation of Batf 
transcript observed in thymocytes lacking Cul3 did not depend 
on TCR signaling.
Bcl6–Cul3 complexes in fresh thymocytes
Human cortical thymocytes were previously shown to ex-
press the Bcl6 protein (Hyjek et al., 2001), and their mouse 
counterparts transiently express Bcl6 mRNA at the DP stage 
according to a public database (ImmGen). Flow cytometric 
analysis of WT mouse thymocytes revealed high amounts of 
Bcl6 in DP thymocytes and rapid down-regulation in SP cells 
(Fig. 6 a). Notably, the thymic expression levels were compa-
rable or superior to those elicited after immunization in pe-
ripheral Tfh cells.
Immunoprecipitation of Cul3 followed by Western blot 
analysis of fresh DP thymocytes demonstrated that >20% of 
Bcl6 was bound to Cul3 (Fig. 6 b). Other BTB-ZF transcrip-
tion factors such as Bach2 and c-Krox, which are expressed 
later at the SP stage, were not coprecipitated by anti-Cul3 
antibodies in SP cells. The binding of Bcl6 to Cul3 was further 
confirmed by transfection in HeLa cells (Fig. 6 c). Although 
single transfection experiments in HeLa cells showed that 
Bcl6 located to the nucleus and Cul3 was mainly found in the 
cytosol, cotransfection resulted in the transport of Cul3 to the 
nucleus. Furthermore, nuclear transport depended on the Cul3 
residues L52 and E55, which were previously shown to be 
specifically involved in binding BTB proteins (Fig. 6 c, bot-
tom row; Wimuttisuk and Singer, 2007). Altogether, these re-
sults indicated that Bcl6 protein was naturally and transiently 
expressed in mouse DP thymocytes where it was prominently 
associated with Cul3.
Bcl6 binds and regulates the Batf promoter in thymocytes
As Batf was recently shown to be a key inducer of several Tfh 
genes, including Bcl6, cMaf, and Il21 (Ise et al., 2011), the sim-
plest hypothesis explaining the above observations was that Bcl6–
Cul3 complexes exerted a negative feedback on the Tfh program 
by repressing Batf and Bcl6. Recent chromatin immuno-
precipitation (ChIP)–Seq studies of Bcl6-expressing macro-
phages identified Bcl6 binding to the first intron of the Batf 
Figure 6. Bcl6 interaction with Cul3 in thymocytes. (a) Intracellular 
staining of Bcl6 in unimmunized CD4+8+ (DP) and CD4+ SP thymocytes 
and in splenic CD4+ OTII Tg cells transferred into naive recipients and  
immunized with OVA 3 d before analysis. Data are representative of two  
to three independent experiments with two to three mice per group.  
(b) Immunoprecipitation and Western blot analysis of lysates from fresh 
DP or CD4+ SP thymocyte (20 × 106 per immunoprecipitation), as indi-
cated. Data are representative of two independent experiments. Molecular 
mass is indicated in kilodaltons. IN, input lysate. (c) Confocal microscopic 
analysis of Bcl6 and Cul3 in transfected HeLa cells, as indicated. Cul3mut 
has the double mutation (L52AE55A) abolishing binding to BTB domains. 
Data are representative of two independent experiments. Bars, 1 µm.
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gene, which contains a putative Bcl6-binding sequence motif 
(Barish et al., 2010, 2012). Using ChIP-qPCR, we demonstrated 
direct binding of Bcl6 to this intronic region of Batf in fresh 
thymocytes (Fig. 7 a). We also detected binding of Bcl6 to the 
Bcl6 proximal promoter, which includes a binding site previ-
ously identified in B cell lymphoma cells (Wang et al., 2002; 
Pasqualucci et al., 2003), as well as to Prdm1 and Bcl2 (Parekh 
et al., 2007). Thus, these findings demonstrated that, despite its 
transient expression, Bcl6 protein did bind key regulatory ele-
ments of multiple genes in fresh DP thymocytes.
Notably, Batf transcripts were significantly up-regulated 
in Bcl6cKO CD4+ SP thymocytes, supporting the conclusion 
that Bcl6 and Cul3 together regulate Batf during thymic devel-
opment (Fig. 7 b). Furthermore, we detected a significant 
increase in the mRNA segment encompassing the exon 2–3 
junction of Bcl6 in exon 7–9–deleted Bcl6cKO compared with 
WT (Fig. 7 b). These findings are consistent with an inhibitory 
function of Bcl6 on the transcription of Batf and Bcl6.
To further dissect how Bcl6 could regulate the transcrip-
tion of Batf, we cotransfected Bcl6 along with a luciferase-
based Batf reporter in HeLa cells (Fig. 7 c). The pBATF-luc 
plasmid alone was strongly repressed in cells cotransfected 
with Bcl6. As there were at least two potential binding sites for 
Bcl6 in the first intron of Batf based on sequence analysis, we 
examined the effects of individual and double mutations at 
these sites. Only the double mutation significantly relieved the 
repression mediated by Bcl6, suggesting that the two binding 
sites were used in vivo. Altogether, these results indicated that 
Bcl6 could directly bind regulatory elements repressing Batf 
transcription in thymocytes.
Cul3-dependent epigenetic changes in the Batf gene
Because the up-regulation of Batf mRNA begins in Cul3cKO 
DP thymocytes and persists after emigration to the periphery, 
at a time when there is little residual Bcl6, we examined 
whether Cul3 might have helped establish lasting epigenetic 
marks in the Batf gene. A significant increase in H3K4Me3 
and H3Ac marks were detected in Cul3cKO CD4+ SP thy-
mocytes, mostly around the first intron region harboring the 
Bcl6-binding sites (Fig. 7 d). Thus, deletion of Cul3 at the DP 
stage resulted in altered epigenetic marks at the Batf gene in 
emerging CD4+ T cells.
Cul3 ablation in mature CD4+ T cells
In Cul3cKO mice, the early dysregulation of Tfh-inducing 
genes in thymocytes preempted the assessment of an additional 
role of Cul3 during antigen stimulation of mature CD4+ T cells. 
To test whether a similar autoregulatory feedback existed in 
Figure 7. The Bcl6–Cul3 complex directly regulates Batf and 
Bcl6. (a) ChIP-qPCR analysis of Bcl6 binding to the indicated genes in 
fresh thymocytes. Data are representative of two independent experi-
ments (mean ± SEM). (b) qRT-PCR analysis of Batf and of Bcl6 (exons  
2–3) in exon 7–9–deleted Bcl6cKO versus WT CD4+ SP thymocytes. Bar 
graphs represent mean ± SEM from five pairs of KO and controls from 
two independent experiments. (c) Transfection of Bcl6 together with 
luciferase-based reporters of Batf in HeLa cells. Mutated intronic regu-
latory sequences (m1 and m2) are as indicated. Bar graphs represent 
mean ± SEM from two independent experiments. (d) ChIP-qPCR analysis 
of H3K4me3 and acetyl-H3 along the Batf gene (indicated at bottom) in 
Cul3cKO versus littermate (LM) control CD4+ SP thymocytes. Bcl6-binding 
sequences are at 0.58 and 0.7 kb in the first intron. Data are representa-
tive of two independent experiments (mean ± SEM). *, P < 0.05; **, P < 0.01; 
***, P < 0.001.
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genes Bcl6 and Batf. Third, and unexpectedly, it shows that the 
feedback loop also operates before antigen encounter by epi-
genetic marking during thymic development.
The BTB domain of the transcription factor Bcl6 ho-
modimerizes to provide a platform that recruits a complex set 
of proteins with transcriptional regulatory activity. These in-
clude the corepressor proteins NCOR and SMRT, which 
bind in a mutually exclusive manner in a groove formed at 
the dimer interface, the MTA3 subunit of the nucleosome re-
modeling and deacetylase complex, the DNA methyltransfer-
ase DNMT1, the histone deacetylase HDAC1, and Polycomb 
group proteins (Basso and Dalla-Favera, 2012). Cul3 is known 
to directly bind BTB proteins and use them as adaptors for 
substrate recognition and ubiquitination (Duda et al., 2011; 
Errington et al., 2012). In a previous study of PLZF, a BTB-
ZF transcription factor which directs NKT lineage cell dif-
ferentiation, we demonstrated that the targets of ubiquitination 
included histone proteins and the genome organizers SATB1 
and LaminB1, which colocalized with PLZF in the nuclear 
environment, but not the BTB protein itself (Mathew et al., 
mature CD4+ T cells undergoing Tfh cell differentiation, we 
deleted Cul3 by retroviral expression of Cre recombinase in 
Cul3fl/fl OTII Tg CD4+ splenocytes. After transduction, cells 
were reinjected into naive hosts, which were subsequently im-
munized with OVA, following the same protocol as in Fig. 3. 
Fig. 8 shows that the GFP-expressing cells derived after trans-
duction with MIGR1-Cre, but not control MIGR1, also exhib-
ited a highly significant exaggeration of Tfh cell differentiation 
at various times after immunization (P < 0.001). Thus, we con-
clude that the Cul3-mediated negative feedback of Tfh cell dif-
ferentiation also operates in mature CD4+ T cells undergoing 
antigen stimulation.
DISCUSSION
This study provides several new insights into the regulation of 
Tfh responses. First, it reveals the exquisite role of Cul3, the E3 
ligase which is specifically recruited by Bcl6, in regulating the 
Tfh transcriptional program of CD4+ T cells. Second, it estab-
lishes the existence of a potent negative feedback loop whereby 
Bcl6–Cul3 complexes can directly repress the key Tfh-inducing 
Figure 8. Cul3 regulates Tfh responses in mature CD4+ splenocytes. CD4+ splenocytes from OTII Tg Cul3fl/fl mice were transduced with MIGR1  
retrovirus expressing Cre and GFP, or GFP alone, as indicated, and injected into CD45 congenic recipients 24 h before immunization with OVA + alum, as 
described in Fig. 3. Mice were analyzed 5 and 7 d after immunization, as indicated. The first column shows the fraction of GFP+ cells among donor cells 
(CD45.2+) at time of recovery. The second and third columns show staining of gated CD4+ donor cells separated according to GFP expression. The fourth 
column shows summaries of individual data. Numbers represent the percentage of PD1hiCXCR5hi Tfh cells based on three separate experiments for day 5 
(n = 5) and day 7 (n = 6). Horizontal bars indicate mean. ***, P < 0.001.
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The derepression of Bcl6 and Batf occurred in the thymus 
and, in the case of Batf, was clearly associated with an increase 
in active epigenetic marks. Although a broader analysis of epi-
genetic changes should reveal the biochemical details and the 
extent of the Bcl6–Cul3-mediated repression program in thy-
mocytes, the current results provide a simple explanation for 
the increased basal overexpression of these key Tfh-inducing 
genes detected first at the mRNA level in thymocytes, and 
then at the protein level around the time of emigration. Flow 
cytometric analysis of Batf and Bcl6 demonstrated that these 
changes were widespread at the single-cell level as shown by 
the global shifts of FACS profiles and therefore seemed suffi-
cient to explain the long-range effect in mature peripheral CD4+ 
T cells and their exaggerated induction of Batf and Bcl6 upon 
antigen stimulation. However, because ablation of Cul3 directly 
in mature post-thymic T cells also resulted in sustained Tfh 
responses, indicating that the negative autoregulatory feedback 
operated also during the peripheral activation of mature CD4+ 
T cells, it remains unclear whether the thymic-stage alterations 
alone are sufficient to deregulate Tfh responses.
There is increasing understanding that Tfh responses are 
exquisitely regulated at multiple levels and through separate 
mechanisms. For example, previous studies have highlighted 
the relevance of TCR signal strength during antigen stimula-
tion (Fazilleau et al., 2009; Deenick et al., 2010; Tubo et al., 
2013). Another level of regulation of Tfh responses is mediated 
by the E3 ligases roquin 1 and 2, which act independently of 
Bcl6 and directly bind Icos mRNA to regulate its degradation 
(Vinuesa et al., 2005; Glasmacher et al., 2010; Pratama et al., 
2013; Vogel et al., 2013). In contrast with these reported mech-
anisms, our study showed that the regulation of Tfh-inducing 
genes by Cul3 was independent of TCR signal strength and 
occurred directly at the level of Batf and Bcl6 transcription.
The Tfh expansion of Cul3cKO mice was conspicuously 
localized to mucosal draining lymph nodes and spleen and was 
not associated with the florid signs of systemic autoimmunity 
reported in san/san mice. This difference might suggest the 
presence of additional defects in san/san and roquin-deficient 
T cells (Pratama et al., 2013). Alternatively, associated B cell 
defects might be required to produce anti-DNA antibodies, as 
suggested by the absence of systemic autoimmunity in mice 
lacking roquin 1 and 2 selectively in their T cell department 
(Vogel et al., 2013). Rather than autoimmunity, a key role for 
environmental antigens is suggested by the mucosal distribution 
of the Tfh expansion in Cul3cKO mice and the requirement 
for antigen stimulation implied by the TCR Tg experiments. 
Future studies will address the role that microbiota and dietary 
antigens might play in these immune responses.
Bcl6-deficient mice were initially reported to exhibit poor 
health and eosinophilic infiltration of heart and lung, with Th2 
skewing of their responses to environmental and experimental 
antigens (Dent et al., 1997; Ye et al., 1997). This dysregulation 
likely results from the combination of cell-intrinsic defects in 
several of the cell types in which Bcl6 is expressed, including 
macrophages, T cells, and B cells (Kusam et al., 2003; Mondal 
et al., 2010; Barish et al., 2012; Hollister et al., 2013). Unlike 
2012). Thus, Bcl6 is associated with a complex set of partner 
proteins that can mediate various epigenetic modifications at 
different target sites, and selective disruptions of these inter-
actions have the potential to reveal novel functions of Bcl6 
(Huang et al., 2013).
The conditional ablation of either Cul3 or Bcl6 in thymo-
cytes resulted in significant changes of expression of Batf and 
of Bcl6 itself, revealing a negative feedback loop exerted by 
Bcl6–Cul3 complexes in thymocytes. This regulation involved 
the direct binding to, and repression of, Batf, a global initiator 
of the Tfh pathway, which is essential for induction of Bcl6, 
cMaf, and Il21 (Betz et al., 2010; Ise et al., 2011). In addition, 
as previously reported for B cell lymphomas (Pasqualucci et al., 
2003), our studies suggested that, in thymocytes, Bcl6 could also 
bind and repress its own gene in an autoregulatory loop. Thus, 
our findings identify a potent negative feedback loop built 
into the Tfh program, an unusual feature among other T helper 
effector programs, which generally show self-reinforcement 
rather than self-limitation. Notably, previous studies demon-
strated that Bcl6 could induce several genes associated with 
the Tfh program, including the endogenous Bcl6 itself (Nurieva 
et al., 2009), after overexpression in vitro. Although this study 
of Bcl6 autoinduction is in apparent conflict with our find-
ings, we note that our results were obtained in vivo and that 
negative autoregulation of Bcl6 has also been demonstrated in 
B cells (Pasqualucci et al., 2003). Thus, it is possible that Bcl6 
might contribute to both its induction and feedback inhibi-
tion, perhaps depending on the stage of the Tfh response, the 
level of Bcl6 expression, or the changing environment of other 
transcription factors associated with the Bcl6 network. Although 
our findings are consistent with the possibility that Cul3 reg-
ulated Bcl6 function, for example through the ubiquitination 
of critical components of the Bcl6 transcriptional complex, as 
suggested for PLZF (Mathew et al., 2012), the precise nature 
of these changes and their causal relationship remain elusive. 
It is also possible that Cul3 directly ubiquitinates Bcl6, thereby 
altering its function or its lifespan, although we have failed to 
document such changes so far. In any case, our findings clearly 
document the key role of Cul3 in regulating the Bcl6-mediated 
Tfh program, providing an explanation for the exaggerated 
Tfh responses in the absence of Cul3 in vivo.
It is noteworthy that conditional ablation of Cul3 in B cells 
resulted in the loss of GC formation (Mathew et al., 2012), 
whereas ablation in T cells increased Tfh cell differentiation and 
GC formation. It has been shown that by modulating the DNA 
damage response and controlling apoptosis, Bcl6 was critical for 
B cells to tolerate the DNA breaks associated with somatic 
hypermutation (Parekh et al., 2007). This critical antiapoptotic 
function of Bcl6 in GC B cells might explain why the absence 
of Cul3 has such drastic consequences. Interestingly, mice engi-
neered to express a mutant form of Bcl6 lacking the ability to 
bind the corepressor NCOR also exhibited markedly dimin-
ished GC formation, whereas Tfh generation appeared intact 
(Huang et al., 2013). These studies emphasize the exquisite 
functional impact of individual components of Bcl6 transcrip-
tional complexes at different genes or in different lineages.
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were analyzed on an LSRII (BD) or sorted on a FACSAria (BD) or MoFlo 
(Dako). Data were analyzed using FlowJo software (Tree Star).
Generation of bone marrow chimeras. 6–8-wk-old B6 (CD45.1 or 
CD45.1/CD45.2) mice were irradiated (100 Gy) using a gamma cell 40 ir-
radiator with a cesium source and i.v. injected with 2–5 × 106 bone marrow 
cells from donor mice after T cell depletion using anti-CD3 and AutoMACS 
(Miltenyi Biotec). The recipient mice were analyzed 8–10 wk after irradiation.
Antinuclear antibodies. Serum dilutions were incubated with Hep-2 cells 
(AN-1012; MBL International), followed by FITC-conjugated anti–mouse 
IgG (eBioscience). Mean nuclear fluorescence intensities of 20 cells per sam-
ple were recorded using ImageJ software (National Institutes of Health). 
Positive control included a serum from MRLlpr/lpr mice.
OTII cell stimulation. For in vitro OTII cell stimulation, thymocytes were 
depleted of CD69+ cells using PE-conjugated anti-CD69 and anti-PE mag-
netic microbeads followed by AutoMACS. 5 × 104 CD69-depleted thymo-
cytes were incubated with 5 × 105 CD3-depleted CD45 congenic spleno-
cytes and cultured with a range of OVAp (323–339) concentrations (Gen-
Script) in duplicate in 96-microwell plates for 20 h at 37°C before FACS 
analysis. For in vivo cell transfer experiments, 5 × 105 CD8-depleted thymo-
cytes from OTII or OTII Cul3cKO mice were i.v. transferred into CD45 
congenic recipient mice 1 d before i.p. injection of 50 µg OVA (Worthington 
Biochemical Corporation) mixed 1:1 with alum (Thermo Fisher Scientific) or 
s.c. injection in the left and right hock of a total of 50 µg OVA mixed 1:1 with 
CFA (Sigma-Aldrich). Each mouse was injected s.c. in the left and right hind 
hock with 50 µl of the CFA emulsion containing 25 µg of OVA protein. OTII 
cells in recipient spleens were characterized by FACS after identification based 
on anti-CD45 allele-specific antibodies, anti-V5 and anti-V2 antibodies.
Tfh-dependent antibody response to NP hapten. To measure the 
T helper–dependent antibody response to the hapten NP, 5 × 105 CD8-depleted 
thymocytes from OTII or OTII Cul3cKO mice were i.v. transferred into 
CD45.1/CD45.2 congenic recipient mice 1 d before i.p. immunization with 
50 µg OVA-NP16 (Biosearch Technologies) mixed 1:1 with alum. Serum was 
collected 0 and 21 d later to titer anti-NP antibodies by ELISA against BSA-
NP41 or BSA-NP4 (Biosearch Technologies) coated on 96-well plates, using 
anti-IgG1 isotype-specific antibodies (BD). Values between different experi-
ments were normalized to the same serum standard.
RTE assay. 6–8-wk-old mice were injected with 5 µl of a 1 mg/ml solu-
tion of FITC (Sigma-Aldrich) into each thymic lobe under anesthesia and 
killed 20 h later for analysis of FITC+ spleen cells.
Retroviral infection. MIGR1 or MIGR1-Cre (Pear et al., 1998) was trans-
fected into Plat-E cells, and viral supernatants were collected 48 and 72 h 
later. Splenic CD4+ cells were enriched by MACS depletion with a mixture 
of anti-B220, -CD19, -Ter119, and -CD8a and stimulated with plate-bound 
anti-CD3 (5 µg/ml) and anti-CD28 (2 µg/ml) for 24 h before infection with 
viral supernatant (1 ml for 106 cells) in the presence of 5 µg/ml polybrene by 
spin infection for 90 min at 800 g. After transduction, 106 cells were injected 
i.v. into CD45 congenic mice, followed by i.p. immunization 24 h later with 
50 µg OVA in alum (1:1).
Transient transfection of HeLa cells. HeLa cells were transfected using 
Lipofectamine (Invitrogen) as per the manufacturer’s instruction with 0.5 µg 
Bcl6 and 2 µg Cul3 plasmids. Cells were harvested 24 h after transfection for 
confocal microscopy.
qRT-PCR. For qRT–PCR, total RNA was prepared from 106 sorted thy-
mic CD4+ SP (CD4+CD8TCRCD25CD1d–GalCer tetramer), 
large DP (CD71+FSChi) or small DP (CD71FSClo) cells from Cul3cKO or 
Bcl6cKO, and their littermate controls by using TRIzol (Invitrogen), the 
RNeasy kit (QIAGEN), and reverse transcription with the Superscript III 
Cul3cKO mice, Bcl6cKO mice did not exhibit Tfh expansion 
because this process requires Bcl6 itself, but their CD4+ SP 
thymocytes did exhibit elevated basal levels of Batf, which, in 
conjunction with Irf4, can bind and activate many T helper ef-
fector genes (Ciofani et al., 2012; Glasmacher et al., 2012; Li 
et al., 2012; Tussiwand et al., 2012). In the absence of Bcl6, these 
derepressed factors might promote aberrant T helper effector 
responses that cause inflammatory pathology.
In conclusion, our findings reveal the role of Cul3 in the 
transcriptional repression of key Tfh-inducing genes by Bcl6, 
identifying a negative autoregulatory loop that is critical for 
limiting Tfh responses. This negative regulation operates when 
mature CD4+ T cells develop Tfh responses in response to anti-
gen in the periphery, but also during thymic development where 
the transient expression of Bcl6 appears to imprint multiple 
Tfh genes before thymocyte maturation and export.
MATERIALS AND METHODS
Mice. C57BL/6, B6.SJL-Ptprca Pep3b/BoyJ (CD45.1), and Cd4-Cre (B6 
Tg(cd4-cre)1Cwi) mice were obtained from the Jackson Laboratory. MHC 
II/ (I-Ab/), MHC I/ (2microglobulin/), and MHC I/II/ mice 
in B6 background were purchased from Taconic. Sh2d1a (SAP)/ (Wu et al., 
2001) and Cul3fl/fl mice (McEvoy et al., 2007) in a B6 background were bred 
in our colony. We used CreCul3fl/fl mice as controls for Cul3cKO and OTII 
CreCul3fl/fl as controls for OTII Cul3cKO. Bcl6fl/fl mice have been de-
scribed previously (Hollister et al., 2013). All mice were raised in a specific 
pathogen–free environment at the University of Chicago, and experiments 
were performed in accordance with the guidelines of the Institutional Ani-
mal Care and Use Committee.
Cell culture. HeLa cells were maintained in DMEM (Gibco) plus 10% 
FBS, 1% penicillin/streptomycin. All of the cell lines were initially pur-
chased from the ATCC.
Bcl6 and Cul3 plasmids and antibodies. Human pcDNA3-myc-Cul3 and 
pcDNA3-myc-Cul3mut (L52AE55A) were previously described (Mathew et al., 
2012). pcDNA3-Bcl6 was provided by B. Baron (University of Chicago, Chicago, 
IL). Anti-Myc (71D10 from Cell Signaling Technology or 9E10 from EMD 
Millipore) and anti-Bcl6 (Santa Cruz Biotechnology, Inc.) were used to stain 
confocal microscopy slides as described previously (Mathew et al., 2012).
Western blot analysis. 20 × 106 thymic DP or CD4+ SP from B6 mice were 
lysed and immunoprecipitated with anti-Cul3 antibody (C-0871; Sigma- 
Aldrich) and Western blotted with anti-Bcl6 (BD), anti–c-Krox (Abcam), 
anti-Bach2 (Novus Biologicals), and anti-Cul3 (Singer et al., 1999).
Flow cytometry. Fluorochrome-labeled monoclonal antibodies against CD4 
(GK1.5), CD8a (53-6.7), TCR (H57-597), CD44 (IM7), CD25 (PC61), 
B220 (RA3-6B2), CXCR5 (2G8), PD1 (29F.1A12, J43), ICOS (C398.4A), 
Fas (JO2), GL7 (GL7), CD3e (17A2), CD45.1 (A20), CD45.2 (104), CD19 
(ID3), IgD (11-26c.2a), CD69 (H1.2F3), -TCR (GL3), V2 (B20.1), V5 
(MR9-4), CXCR5 (L138D7), BTLA (HMBT-6B2), and OX40 (OX86) were 
purchased from e-Bioscience, BD, or BioLegend. We used either fluorophore-
conjugated CXCR5 antibody (L138D7) or purified CXCR5 (2G8) antibody. 
For CXCR5 staining using purified antibody, cells were first incubated with 
5 µg/ml of purified anti-CXCR5 (2G8; BD), followed by biotinylated Affini-
Pure anti–rat IgG (Jackson ImmunoResearch Laboratories, Inc.) and APC-
streptavidin (Invitrogen). After addition of 100 µg/ml of purified rat IgG2a 
isotype, cells were incubated with other extracellular antibodies. Bcl6 (clone 
K12-91; BD), Batf (clone MBM7C7; eBioscience), Foxp3 (clone FJK-16s; 
eBioscience), Tbet (clone 4B10; BioLegend), Ki-67 (clone SolA15; eBiosci-
ence), and Gata3 (TWAJ; eBioscience) were stained after fixation and per-
meabilization with the Foxp3 staining buffer set from eBioscience. Samples 
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Bcl6-binding site, a site-directed mutagenesis kit (Agilent Technologies) was 
used to change the sequences from 5-TTTCTAGGAA-3 (576/585: Bcl6_1) 
and 5-TTTCCAGGAA-3 (696/705: Bcl6_2) to 5-TTGTCGACTA-3 
(m1) and 5-TTGATATCGAC-3 (m2), respectively. These plasmids were 
transfected along with a cmv-Renilla plasmid into 293T cells (ATCC) using 
Lipofectamine (Invitrogen). Reporter assays were performed using the dual 
luciferase detection system (Promega), and firefly luciferase levels were nor-
malized to Renilla luciferase values.
Microarray analysis, strictly standardized mean difference (SSMD), 
and Monte Carlo analysis. RNA was isolated from FACS-sorted thymic 
CD4+ SP cells (CD4+CD8TCRCD25CD1d–GalCer tetramer) 
from 4.5-wk-old Cul3cKO and littermate controls using TRIzol and pro-
cessed for 430A.v2 arrays (Affymetrix) according to the manufacturer’s in-
structions. To test whether Tfh-related genes were non-randomly up-regulated 
in Cul3cKO thymocytes, we compared the SSMDs of Tfh-, Th1-, and Th2-
related genes with the SSMDs of randomly generated subsets of genes. First, 
we selected Tfh-related genes (Slamf6, Il21, Cxcr5, Maf, Icos, Irf4, Batf, Bcl6, 
Pdcd1, Sh2d1a, Tiam1, Stat4, Tnfsf11, and CD44), Th1 genes (Eomes, Tbet, 
Fasl, IL12rb2, Ifng, IL18rap, Stat1, Stat4, IL27ra, IL18r1, Cxcr3, Zbtb32, and 
Ccr5), and Th2 genes (pparg, Il5, Ccr1, Il1rl1, Areg, Il13, Il4, Gata3, Ccr3, 
Il13ra1, Il24, Ccr8, Ccr4, Stat6, IL4ra, Ccl5, Il9, and Ccl11) based on previously 
published work (Vinuesa et al., 2005; Nurieva et al., 2008; Yusuf et al., 2010). 
Then, drawing from all genes represented on the microarray, we generated 
10 million randomly selected, equally sized subsets of genes using the Monte 
Carlo method, producing an ensemble of gene sets to serve as a null distribu-
tion of possible observed effects. For each set of genes, we compared probe 
set intensities between Cul3 KO mice and their WT littermates, quantifying 
the overall effect size using a paired-sample SSMD (Zhang, 2011). The SSMD 
for paired observations is defined as the mean of the log fold changes (FC) 
divided by the standard deviation of the log fold changes:
	 SSMD FC FC FC
FC FC FC
= ( )( )
µ
σ
1 2
1 2
, ,...,
, ,...,
.n
n
	
FCn denotes the log fold change for the n-th observation with respect to a 
negative reference,  is the arithmetic mean, and  is the standard deviation. 
The SSMD of the Tfh-related probe sets estimates the effect size of Cul3 
deficiency on Tfh-specific genes, whereas the SSMDs for the randomly gen-
erated sets approximate the distribution of possible effects observed by chance 
alone. To estimate the statistical significance of Tfh-related gene up-regulation, 
we compared the SSMD of Tfh genes (SSMDTfh = 0.788) with the Monte 
Carlo–generated distribution of random SSMDs. In our sample of 10 million 
sets of genes, SSMDs greater than or equal to SSMDTfh occurred 24 times, 
corresponding to a p-value of 2 × 106. A similar analysis conducted for the 
Th1 and Th2 gene sets showed nonsignificant p-values of 0.3 in each case.
Statistical analysis. Unpaired Student’s t test was performed with Prism 
(GraphPad Software). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Accession number. Gene expression data are available at the Gene Expres-
sion Omnibus (GEO) database under accession no. GSE56514.
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first strand synthesis super mix cDNA kit (Invitrogen). cDNA expression was 
determined with the Mx3005P using Brilliant SYBR green master mix 
(Agilent Technologies). Fluorescence signals were measured over 40 PCR 
cycles, and the cycle (Ct) at which signals crossed a threshold set within the 
logarithmic phase was recorded. The Ct for the target gene was subtracted 
from the Ct for 18S (Ct), and Ct was calculated by subtracting Ct for 
KO from Ct for littermate (Ct). The fold change of mRNA in KO over 
littermate was calculated as 2Ct.
ChIP-qPCR. ChIP experiments were performed as previously described 
(Mathew et al., 2012). In brief, cells were fixed and isolated nuclei were 
resuspended in 130 µl nuclei lysis buffer (50 mM Tris-HCl, pH 8.1, 10 mM 
EDTA, 0.5% SDS, and 1× protease inhibitor) sonicated to obtain 100–500-bp 
fragments (Covaris-S220). Chromatin from 20 million cells was used for 
immunoprecipitation using anti-Bcl6 (sc-N3), anti-H3K4me3 (07-473; 
EMD Millipore), or anti-H3Ac (06-599; EMD Millipore). Specific DNA 
sequences were assessed by qRT-PCR using primers as listed.
qRT-PCR primers. The following qRT-PCR primers were used: batf_f, 
5-ACAGACACAGAAAGCCGACAC-3; batf_r, 5-CTCGGTGAGCT-
GTTTGATCTC-3; bcl6_f, 5-ACTGGGCAAACACAACATGG-3; bcl6_r, 
5-GGAGGCGATTAAGGTTGAGAAG-3; bcl6_exon 2–3_f, 5-ACT-
GGGCAAACACAACATGG-3; bcl6_exon 2–3_r, 5-GGAGGCGATTA-
AGGTTGAGAAG-3; il21_f, 5-GCCAAACTCAAGCCATCAAACC-3; 
il21_r, 5-TTCTCATACGAATCACAGGAAGGG-3; c-maf_f, 5-AGC-
AGTTGGTGACCATGTCG-3; c-maf_r, 5-TGGAGATCTCCTGCTTG-
AGG-3; 18s_f, 5-TTGACTCAACACGGGAAACC-3; 18s_r, 5-ACC-
CACGGAATCGAGAAAGA-3; gapdh_f, 5-CTGGAGAAACCTGCC-
AAGTATG-3; and gapdh_r, 5-TCCTCAGTGTAGCCCAAGATG-3.
Bcl6 ChIP-qPCR primers. The following Blc6 ChIP-qPCR primers were 
used: bcl6-f, 5-GGGTTCTTAGAAGTGGTGATGC-3; bcl6-r, 5-CA-
GCAACAGCAATAATCACCTG-3; batf-f, 5-CGTCTCTGCCACTTA-
GGTTCC-3; batf_r, 5-TGGAACATTCCTCTGCTTATGG-3; bcl2-f, 
5-TCTGCCCTGGAGGTCTGAAG-3; bcl2-r, 5-CTGTGATTCTCC-
CTTCTTCTCG-3; prdm1-f, 5-TGCAGAACTTCTAGGTTCTTTCTTG-
3; and prdm1-r, 5-GCTTTGGAAGGTTCTGAATGG-3.
Histone ChIP-qPCR primers. The following histone ChIP-qPCR primers 
were used: batf(100)-f, 5-TCGCTCTGCCTTTCAAACTG-3; batf(100)-r, 
5-AAGTCACATGGGCGGAAAC-3; batf(+580bp)-f, 5-CGTCTCTGC-
CACTTAGGTTCC-3; batf(+580bp)-r, 5-TGGAACATTCCTCTGC-
TTATGG-3; batf(+700bp)-f, 5-TGTTCCAGTAGATCGCTGCTTC-3; 
batf(+700bp)-r, 5-TCTGTCTTGCCACTTGCTTG-3; batf(+1.5kb)-f, 
5-TTGCCCTCTCTAACCCAATG-3; batf(+1.5kb)-r, 5-CTTGG-
GTCAGGTTCTGATTCC-3; batf(+2k)-f, 5-AACGCGCTTGTA-
CAGAAGTTG-3; batf(+2k)-r, 5-TGCGCACATGCTAAACCTTC-3; 
batf(+2.5k)-f, 5-CCTCCTGAGGCTTCAATTTCTC-3; batf(+2.5k)-r, 
5-TCTTCAGCATTCCCTGCTACC-3; batf(+3k)-f, 5-CAGGTT-
GTGGAAAGGGCTTC-3; batf(+3k)-r, 5-AGAAAGGTTCAGTGTC-
CAGTGC-3; batf(+3.5k)-f, 5-TCATCGCATCCTTCTTCCTG-3; 
batf(+3.5k)-r, 5-CTTATCTGGGTTTGGCACCTC-3; batf(+4k)-f, 
5-TCACACACGCATGTGCATC-3; batf(+4k)-r, 5-TATGTGCGTGT-
GGTGTTTCC-3; batf(+9.5k)-f, 5-ATGTCTGCGAGGCTGAATTG-3; 
batf(+9.5k)-r, 5-CCACCATTGGTAATTTGGAGAC-3; batf(+18.5k)-f, 
5-TGATGGGCCTAACCACATTC-3; batf(+18.5k)-r, 5-TAGGCAGT-
GTGGAGATCAAGC-3; batf(+18.8k)-f, 5-TCCGAGCTTACAGACA-
TTCCTC-3; batf(+18.8k)-r, 5-TGACTAACCACTGCCTGCTG-3; 
batf(+19.4k)-f, 5-AGCATTCAAAGTGTCGCTGAG-3; batf(+19.4k)-r, 
5-TTAAGTTGTGGAGGAGCAGAGG-3; batf(+20k)-f, 5-CAAGC-
TTCTGGCCTGAAATG-3; and batf(+20k)-r, 5-CCCGGACC-
TGAATAAACAGAAC-3.
Reporter assay. The proximal promoter, first exon, and first intron con-
taining the Bcl6-binding motif of mouse Batf (572 to 924) were cloned 
into the SmaI and XhoI site of pGL3-basic vector (Promega). To disrupt the 
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